Showing posts with label Pharmaceuticals. Show all posts
Showing posts with label Pharmaceuticals. Show all posts
Monday, January 13, 2025

Royalty Pharma (NASDAQ: RPRX) is popping in 2025! There are reasons for that as markets swoon!

›
  Royalty Pharma (NASDAQ: RPRX) Ed Note: We bought RPRX in Sept 2024 and posted this report: Why we like and own shares of, Royalty Pharma p...
Wednesday, October 9, 2024

While speculating on possible BioTech takeover targets, Ginkgo Bioworks jumped off the page, keeping in mind that speculation is a double edged sword!

›
  Ginkgo Bioworks is recognized as a leader in synthetic biology, specializing in the design and programming of custom organisms for a varie...
Wednesday, July 10, 2024

Two years ago! That was the last time you could buy shares of Recursion Pharmaceuticals (NASDAQ: RXRX) at today's price! Here's why!

›
  Recursion Pharmaceuticals (NASDAQ: RXRX)   recently raised approximately $200 million through a public offering of 30,769,230 shares of it...
Tuesday, June 18, 2024

Acquisitions in Biotech and SynBio stocks are on the horizon again and here is one that we believe may be in the crosshairs!

›
 Ginkgo Bioworks operates several advanced biotechnology platforms and technologies that would be particularly attractive to an acquiring co...
Sunday, May 12, 2024

Recursion Pharmaceuticals is at the forefront of AI-driven drug discovery!

›
  Recursion Pharmaceuticals  has caught the attention of major pharmaceutical companies due to its innovative approach to drug discovery. Mo...